TG Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TGTX and other ETFs, options, and stocks.

About TGTX

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib.

CEO

Michael Sean Weiss

CEOMichael Sean Weiss

Employees

264

Employees264

Headquarters

Morrisville, North Carolina

HeadquartersMorrisville, North Carolina

Founded

1993

Founded1993

Employees

264

Employees264

TGTX Key Statistics

Market cap

2.55B

Market cap2.55B

Price-Earnings ratio

74.74

Price-Earnings ratio74.74

Dividend yield

—

Dividend yield—

Average volume

3.42M

Average volume3.42M

High today

$17.50

High today$17.50

Low today

$16.34

Low today$16.34

Open price

$17.46

Open price$17.46

Volume

3.27M

Volume3.27M

52 Week high

$31.54

52 Week high$31.54

52 Week low

$6.46

52 Week low$6.46

Analyst ratings

78%

of 9 ratings

Buy

77.8%

Hold

11.1%

Sell